维普期刊资源整合服务平台（V6.5）

56篇 您的检索式：作者名="BISCEGLI J"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Positron emission tomography scanning in the evaluation of hepatocellular carcinoma显示文摘	M.Akram Khan Connie S Combs Elizabeth M Brunt Val J Lowe Michael K Wolverson Harvey Solomon Brian T Collins Adrian M.Di Bisceglie	2000	Journal of Hepatology2000，，5：	2
2	Design and endpoints of clinical trials in hepatocellular carcinoma显示文摘	Llovet JM Di Bisceglie AM Bruix J	2008	Natl Cancer Inst2008，100，10：	1
3	Design and endpoints of clinical trials in hepatocellular carcinoma 显示文摘	Llovet JM Di Bisceglie AM Bruix J etal	2008	Commentary JNCI2008，100，10：	1
4	New therapeutic strategies for hepatitis C显示文摘	McHutchison J Rice CM	2002	Hepatology2002，35，：	1
5	Design and endpoints of clinical trials in hepatocellular carcinoma显示文摘	Llovet J M Di Bisceglie A M Bruix J	2008	J Natl Cancer Inst2008，100，：	1
6	Elevations in serum alpha- fetoprotein levels in patients with chronic hepatitis B 显示文摘	Di Bisceglie A M Hoofnagle J H	1989	Can- cer1989，64，10：	1
7	Hepatic iron concentra tion as a predictor of response to interferon alfa therapy in chronic hepatitis C显示文摘	OLYNYK J K REDDY K R DI BISCEGLIE A M	1995	Gastroenterology1995，108，4：	1
8	Design and endpoints of clinical trials in hepatocellular carcinoma显示文摘	Llovet JM Di Bisceglie AM Bruix J	2008	J Natl Cancer Inst2008，100，10：	1
9	Design and endpoints of clinical trials in hepatocellular carcinoma显示文摘	Llovet JM Di Bisceglie AM Bruix J		0，，10：	1
10	Optimal therapy of hepatitis C显示文摘	DI BISCEGLIE A M HOOFNAGLE J I4	2002	Hepatology2002，36，51：	1
11	Flow visualization studies to improve the spiral pump design 显示文摘	ANDRADE A BISCEGLI J SOUZA J		Artificial Organs0，21，7：	1
12	Design and endpoints of clinical trials in hepatocellular carcinoma 显示文摘	Llovet J M Di Bisceglie AM Bruix J et a l	2008	J Natl Cancer Inst2008，100，10：	1
13	Design and endpoints of clinical trials in hepatocellular eareinoma显示文摘	Llovet J M Di Bisceglie AM Bruix J	2008	J Natl Cancer Inst2008，100，10：	1
14	Design and end- points of clinical trials in hepatocellular carcinoma 显示文摘	Llovet JM Di Bisceglie AM Bruix J	2008	J Natl Cancer Inst2008，100，10：	1
15	Design and endpoints of clinical trials in hepatocellular carcinoma 显示文摘	Llovet JM Di Bisceglie AM Bruix J	2008	J Natl Cancer Inst2008，100，10：	1
16	Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients显示文摘	Ni J Hembrador E Bisceglie AD	2003	J Immunol2003，170，：	1
17	Design and endpoints of clinical trials in hepatocellular carcinoma显示文摘	Llovet JM Di Bisceglie AM Bruix J	2008	J Natl Cancer Inst2008，100，10：	1
18	Telaprevir for previously untreated chronic hepatitis C virus infection 显示文摘	Jacobson IM McHutchison JG Dusheiko G Di Bisceglie AM Reddy KR Bzowej NH Marcellin P Muir AJ Ferenci P Flisiak R George J Rizzetto M Shouval D Sola R Terg RA Yoshida EM Adda N Bengtsson L Sankoh AJ Kieffer TL George S Kauffman RS Zeuzem S ADVANCE Study Team	2011	N Engl J Med2011，364，25：	1
19	Design and end-points of clinical trials in hepatocellular carcinoma显示文摘	Llovet JM Bisceglie AM Bruix J	2008	J NatlCancer Inst2008，100，10：	1
20	Design andendpoints of clinical trials in hepatocellular carcinoma显示文摘	Llovet JM Di Bisceglie AM Bruix J	2008	J Natl Cancer Inst2008，100，10：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示